UBS analyst Jay Sole maintains On Holding (NYSE:ONON) with a Buy and raises the price target from $25 to $35.
Ionis Pharmaceuticals Q3 Sales $160.00M Beat $143.84M Estimate
Ionis Pharmaceuticals (NASDAQ:IONS) reported quarterly sales of $160.00 million which beat the analyst consensus estimate of $143.84 million by 11.23 percent. This is a 20.30 percent increase over sales of $133.00